News & Updates

Show Multimedia Only

Unilateral flank radiation a viable substitute to WAPRT for Wilms tumour

31 Mar 2024

Children with Wilms tumour (WT) treated with abdominal radiation therapy (RT) may opt to receive unilateral flank radiation instead of whole abdominal and pelvic RT (WAPRT) for contained rupture or spillage, suggests a study.

Unilateral flank radiation a viable substitute to WAPRT for Wilms tumour

31 Mar 2024

Adalimumab on par with infliximab in luminal paediatric Crohn's disease

27 Mar 2024

Use of either adalimumab or infliximab as first antitumour necrosis factor (anti-TNF) agent results in positive outcomes among children with Crohn’s disease (CD), a study has shown.

Adalimumab on par with infliximab in luminal paediatric Crohn's disease

27 Mar 2024

Upadacitinib increases time spent with improved AD-related symptoms

26 Mar 2024 by

Treatment with upadacitinib, an oral selective Janus kinase inhibitor, led to greater proportions of days spent with improved nighttime itch and sleep disturbance experienced by patients with moderate-to-severe atopic dermatitis (AD), according to an integrated analysis of the phase III Measure Up 1 and 2 studies presented at AAD 2024.

Upadacitinib increases time spent with improved AD-related symptoms

26 Mar 2024

Adherence to SG’s healthy activity guidelines for early childhood decline with age

25 Mar 2024 by

How children in Singapore meet sleep, screen time, and physical activity recommendations appears to slip as they transition from infants to screen-focused toddlers and preschoolers, according to a study.

Adherence to SG’s healthy activity guidelines for early childhood decline with age

25 Mar 2024

Levodopa helps with gait problems in Dravet syndrome

25 Mar 2024

In patients with Dravet syndrome, treatment with levodopa appears to produce improvements in gait disturbance, as shown in a randomized crossover trial.

Levodopa helps with gait problems in Dravet syndrome

25 Mar 2024

Dupilumab reverses gene dysregulation in EoE

24 Mar 2024 by

Treatment with dupilumab helps normalize the expression of genes dysregulated in children with active eosinophilic esophagitis (EoE), according to a study.

Dupilumab reverses gene dysregulation in EoE

24 Mar 2024

‘Planet-friendly’ foods help improve cardiovascular health in teens

20 Mar 2024

Eating “planet-friendly” foods may result in better cardiovascular (CV) health in adolescents, according to a study involving European participants.

‘Planet-friendly’ foods help improve cardiovascular health in teens

20 Mar 2024

Clinical nutrition knowledge lacking in some paediatricians

20 Mar 2024 by

Physicians in a tertiary paediatric specialist hospital in Singapore report gaps in their nutritional knowledge, particularly regarding special diet, inflammatory bowel disease (IBD), and gastrointestinal allergy, according to a recent study.

Clinical nutrition knowledge lacking in some paediatricians

20 Mar 2024

Original New Drug Application Approvals by US FDA (1-15 March 2024)

20 Mar 2024

New drug applications approved by US FDA as of 1-15 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2024)

20 Mar 2024

Dupilumab mends skin barrier in children with AD, but with caveat

19 Mar 2024 by

Use of dupilumab results in normalization of stratum corneum (SC) lipids, which is responsible for skin barrier function, in children with atopic dermatitis (AD) within 1 to 2 months of treatment, according to a study presented at AAAAI 2024.

Dupilumab mends skin barrier in children with AD, but with caveat

19 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

Unilateral flank radiation a viable substitute to WAPRT for Wilms tumour

Unilateral flank radiation a viable substitute to WAPRT for Wilms tumour

Adalimumab on par with infliximab in luminal paediatric Crohn's disease

Adalimumab on par with infliximab in luminal paediatric Crohn's disease

Upadacitinib increases time spent with improved AD-related symptoms

Upadacitinib increases time spent with improved AD-related symptoms

Adherence to SG’s healthy activity guidelines for early childhood decline with age

Adherence to SG’s healthy activity guidelines for early childhood decline with age

Levodopa helps with gait problems in Dravet syndrome

Levodopa helps with gait problems in Dravet syndrome

Dupilumab reverses gene dysregulation in EoE

Dupilumab reverses gene dysregulation in EoE

‘Planet-friendly’ foods help improve cardiovascular health in teens

‘Planet-friendly’ foods help improve cardiovascular health in teens

Clinical nutrition knowledge lacking in some paediatricians

Clinical nutrition knowledge lacking in some paediatricians

Original New Drug Application Approvals by US FDA (1-15 March 2024)

Original New Drug Application Approvals by US FDA (1-15 March 2024)

Dupilumab mends skin barrier in children with AD, but with caveat

Dupilumab mends skin barrier in children with AD, but with caveat